Azelastine suppresses the release of arachidonic acid metabolites from cultured human umbilical vein endothelial cells
- 1 March 1997
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 56 (3) , 209-211
- https://doi.org/10.1016/s0952-3278(97)90536-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Syosaiko-to and Saiboku-to (Chinese-Japanese herbal medicine) suppress the release of arachidonic acid metabolites from cultured porcine pulmonary artery endothelial cellsJournal of Ethnopharmacology, 1994
- Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cellsJournal of Cellular Physiology, 1992
- Inhibitory effects of histamine H1 receptor blocking drugs on metabolic activations of neutrophils.Journal of Pharmacobio-Dynamics, 1991
- Evaluation of the Safety and Efficacy of Multiple Doses of Azelastine to Adult Patients with Bronchial Asthma over TimeAmerican Review of Respiratory Disease, 1990
- Inhibition of 5-HETE, LTB4, and LTC4 Formation by Azelastine in Rat Mixed Peritoneal CellsInternational Archives of Allergy and Immunology, 1990
- Inhibitions of metabolic responses of polymorphonuclear leukocytes by antiallergic drugs.Journal of Pharmacobio-Dynamics, 1989
- Effect of Azelastine on the Release and Action of Leukotriene C4 and D4International Archives of Allergy and Immunology, 1987
- Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cellsJournal of Allergy and Clinical Immunology, 1984
- Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: Implications for its mode of actionEuropean Journal of Pharmacology, 1983
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973